Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sakar Healthcare Ltd ( (IN:SAKAR) ) has provided an update.
Sakar Healthcare Ltd has announced the acquisition of nine new Marketing Authorizations for its oncology products, bringing the total to eleven across the European Union and emerging markets. This expansion allows Sakar to export a diverse range of cancer treatment products, enhancing its market presence and potentially increasing its export volume in these regions.
More about Sakar Healthcare Ltd
Sakar Healthcare Ltd is a company operating in the pharmaceutical industry, specializing in the development and manufacturing of oncology products. The company focuses on research-driven, vertically integrated production of cancer treatment formulations, with a market focus on Europe and emerging markets.
Average Trading Volume: 16,156
Technical Sentiment Signal: Buy
Current Market Cap: 8.03B INR
Learn more about SAKAR stock on TipRanks’ Stock Analysis page.